Targeted Antibiotic Gel Helps Pilot Patients Avoid Foot Amputation

A Jerusalem-based clinical trial found that GentaGel’s biodegradable antibiotic treatment successfully prevented foot amputations in 80% of patients by delivering medication directly to infection sites over 60 days. The company is now pursuing further trials and FDA approval.